DeepMed Research

Takeda Pharmaceutical Company Ltd

🇯🇵Japan

Country: 🇯🇵Japan

Ownership: -

Established: 1925-01-01

Employees: -

Market Cap: $47.5B

Website: http://www.takeda.co.jp/

Clinical Trials

A Study of the Quality of Life in Adults With Crohn's Disease With Complex Perianal Fistulas

Completed

Conditions: Crohn Disease
Rectal Fistula

First Posted Date: 2021-05-06

Last Posted Date: 2024-08-05

Lead Sponsor: Takeda

Target Recruit Count: 15

Registration Number: NCT04876690

Locations: 🇵🇹
Centro Hospitalar Universitario de Lisboa Central (CHULC), Lisboa, Portugal
🇵🇹
Centro Hospitalar Tondela-Viseu (CHTV), Viseu, Portugal
🇵🇹
Centro Hospitalar e Universitario de Coimbra (CHUC), Coimbra, Portugal

and more 2 locations

A Study in Children, Teenagers and Adults With Severe Hemophilia A Who Switched From Other Factor VIII Treatments to Adynovate

Completed

Conditions: Hemophilia A

Interventions: Other: Non-Interventional

First Posted Date: 2021-05-06

Last Posted Date: 2023-07-24

Lead Sponsor: Takeda

Target Recruit Count: 153

Registration Number: NCT04876365

Locations: 🇨🇦
Hamilton-Niagara Regional Hemophilia Treatment Centre, Hamilton, Ontario, Canada

A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)

Completed

Conditions: Inflammatory Bowel Diseases
Colitis, Ulcerative
Crohn Disease

First Posted Date: 2021-05-05

Last Posted Date: 2024-11-07

Lead Sponsor: Takeda

Target Recruit Count: 335

Registration Number: NCT04873700

Locations: 🇲🇽
Unidad de Enfermedades Reumaticas y Cronico degenerativas, Torreon, Coahuila, Mexico
🇲🇽
Centro De Investigacion Clinica De Alta Especialidad "Cicae", Torreon, Coahuila, Mexico
🇲🇽
Hospital Medica Sur Tlalpan, Ciudad de Mexico, Distrito Federal, Mexico

and more 9 locations

A Study of Vedolizumab in Adults in Real-World Practice

Completed

Conditions: Colitis, Ulcerative
Crohn Disease

First Posted Date: 2021-05-04

Last Posted Date: 2024-07-22

Lead Sponsor: Takeda

Target Recruit Count: 500

Registration Number: NCT04872491

Locations: 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China

and more 37 locations

Post-Marketing Study of Prucalopride Safety In Pregnancy

Recruiting

Conditions: Chronic Idiopathic Constipation (CIC)

Interventions: Other: No Intervention

First Posted Date: 2021-05-03

Last Posted Date: 2024-06-28

Lead Sponsor: Takeda

Target Recruit Count: 616

Registration Number: NCT04869280

Locations: 🇺🇸
University of California San Diego, La Jolla, California, United States

A Study in Teenagers and Adults With Hereditary Angioedema (HAE) Type I or Type II Who Use Lanadelumab as Long-Term Prophylaxis

Completed

Conditions: Hereditary Angioedema (HAE)

First Posted Date: 2021-04-27

Last Posted Date: 2023-01-13

Lead Sponsor: Takeda

Target Recruit Count: 207

Registration Number: NCT04861090

Locations: 🇦🇹
LKH-Universitätsklinikum Klinikum Graz, Graz, Austria
🇦🇹
Kepler Universitätsklinikum Linz, Linz, Austria
🇦🇹
Medizinische Universitat Wien (Medical University of Vienna), Wien, Austria

and more 17 locations

Drug Use Study of Febuxostat After Recent Changes in the Prescribing Information

Completed

Conditions: Cardiovascular Diseases
Gout

First Posted Date: 2021-04-21

Last Posted Date: 2021-04-27

Lead Sponsor: Takeda

Target Recruit Count: 24046

Registration Number: NCT04853160

Locations: 🇺🇸
Central Contact, Cambridge, Massachusetts, United States

A Study Using Artificial Intelligence to Identify Adults With Complex Perianal Fistulas Associated With Crohn's Disease

Completed

Conditions: Crohn Disease
Rectal Fistula

First Posted Date: 2021-04-14

Last Posted Date: 2024-05-10

Lead Sponsor: Takeda

Target Recruit Count: 32

Registration Number: NCT04844593

Locations: 🇪🇸
Hospital Universitario Fundacion Alcorcon, Madrid, Comunidad De Madrid, Spain
🇪🇸
Hospital del Mar, Barcelona, Cataluna, Spain
🇪🇸
Hospital Universitario Son Espases, Palma, Islas Baleares, Spain

A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

Phase 1

Active, not recruiting

Conditions: Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer
Squamous Cell Cancer of Head and Neck (SCCHN)

Interventions: Drug: TAK-186

First Posted Date: 2021-04-14

Last Posted Date: 2025-03-14

Lead Sponsor: Takeda

Target Recruit Count: 97

Registration Number: NCT04844073

Locations: 🇺🇸
UC San Diego Moores Cancer Center, San Diego, California, United States
🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸
University of Colorado - Anschutz Medical Campus - PPDS, Aurora, Colorado, United States

and more 24 locations

An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease

Phase 3

Completed

Conditions: Primary Immunodeficiency Disease

Interventions: Biological: IGSC 20% infusion

First Posted Date: 2021-04-13

Last Posted Date: 2025-01-20

Lead Sponsor: Takeda

Target Recruit Count: 12

Registration Number: NCT04842643

Locations: 🇯🇵
Kurume University Hospital, Kurume, Fukuoka, Japan
🇯🇵
Gifu University Hospital, Gifu, Japan
🇯🇵
Tokyo Medical Dental University Hospital, Tokyo, Japan

and more 5 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy